Transcode Therapeutics Inc trading halted, news pending
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...
TransCode Therapeutics Raises $8M in Private Placement
TransCode Therapeutics ( (RNAZ) ) has shared an announcement.
Why TransCode Therapeutics (RNAZ) Stock Is Diving
TransCode Therapeutics shares are trading lower by 16% during Monday's session. The company announced a 1-for-33 reverse ...
TransCode Therapeutics to execute 1-for-33 reverse stock split on Dec 4
TransCode Therapeutics (NASDAQ:RNAZ) will execute its previously announced 1-for-33 reverse stock split on Dec. 4, 2024. The company’s common stock is expected to begin trading on a split-adjusted ...
TransCode Therapeutics, Inc. Announces $8 Million Private Placement
BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RNAZ), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that it has entered into a ...
TransCode Therapeutics, Inc.: TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company committed to more effectively treating cancer using RNA ...
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that its ...
Transcode Therapeutics issues 21.2M shares at 37.7c in private placement
TransCode Therapeutics (RNAZ) has entered into a securities purchase agreement with certain institutional investors. The aggregate gross cash proceeds are expected to be approximately $8M before ...